Daniel P. Rossignol

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

Steven M. Opal, Pierre‐François Laterre, Bruno François et al. · JAMA · 2013 · 770 citations · Full text

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

Kari Ann Shirey, Wendy Lai, Alison Scott et al. · Nature · 2013 · 412 citations · Full text

Inflammation, Tlr4 Antagonist Eritoran, Innate Immune System +5

E5531, a Pure Endotoxin Antagonist of High Potency

William J. Christ, Osamu Asano, Andrea L. C. Robidoux et al. · Science · 1995 · 321 citations

Pharmacotherapy, Viable Escherichia Coli, Drug Resistance +16

Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist

Maureen Mullarkey, Jeffrey Rose, John R. Bristol et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 290 citations

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

Kenneth R. Cooke, Armin Gerbitz, James M. Crawford et al. · Journal of Clinical Investigation · 2001 · 286 citations · Full text